126 related articles for article (PubMed ID: 8220135)
1. Multiparameter approach in the identification of cross-contaminated leukemia cell lines.
Gignac SM; Steube K; Schleithoff L; Janssen JW; MacLeod RA; Quentmeier H; Drexler HG
Leuk Lymphoma; 1993 Jul; 10(4-5):359-68. PubMed ID: 8220135
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a new Ph1-positive ALL cell line (ALL/MIK) presenting bcr gene rearrangement on bcr-2 and ALL-type bcr/abl transcript: suggestion of in vitro differentiation to monocytoid lineage.
Higa T; Okabe M; Kunieda Y; Kodama S; Itaya T; Kurosawa M; Sakurada K; Maekawa I; Shoji M; Kasai M
Leuk Lymphoma; 1994 Jan; 12(3-4):287-96. PubMed ID: 8167560
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase mRNA analysis in acute lymphoblastic leukemia.
Crisan D; Topalovski M; O'Malley B
Diagn Mol Pathol; 1996 Dec; 5(4):236-48. PubMed ID: 8955614
[TBL] [Abstract][Full Text] [Related]
4. Molecular and phenotypic spectrum of de novo Philadelphia positive acute leukemia.
Lim LC; Heng KK; Vellupillai M; Tan LT; Boey BC; Lau LC; How GF
Int J Mol Med; 1999 Dec; 4(6):665-7. PubMed ID: 10567681
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of human B cell precursor-leukemia cell lines.
Matsuo Y; Drexler HG
Leuk Res; 1998 Jul; 22(7):567-79. PubMed ID: 9680106
[TBL] [Abstract][Full Text] [Related]
6. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
[No Abstract] [Full Text] [Related]
7. Establishment of novel B-cell precursor leukemia sister cell lines NALM-36 and NALM-37: shift of immunoglobulin phenotype to double light chain positive B-cell.
Matsuo Y; Drexler HG; Takeuchi M; Orita K
Leuk Res; 2002 Jan; 26(1):1-10. PubMed ID: 11734297
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and molecular analysis of Ph1-chromosome-positive acute lymphoblastic leukemia cell lines.
Miyagi T; Ohyashiki J; Yamato K; Koeffler HP; Miyoshi I
Int J Cancer; 1993 Feb; 53(3):457-62. PubMed ID: 8428799
[TBL] [Abstract][Full Text] [Related]
9. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
10. BCR/ABL oncoprotein-targeted antitumor activity of antisense oligodeoxynucleotides complementary to bcr/abl mRNA and herbimycin A, an antagonist of protein tyrosine kinase: inhibitory effects on in vitro growth of Ph1-positive leukemia cells and BCR/ABL oncoprotein-associated transformed cells.
Okabe M; Kunieda Y; Miyagishima T; Kobayashi M; Kurosawa M; Itaya T; Sakurada K; Miyazaki T
Leuk Lymphoma; 1993 Jul; 10(4-5):307-16. PubMed ID: 7693103
[TBL] [Abstract][Full Text] [Related]
11. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
[TBL] [Abstract][Full Text] [Related]
12. Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia.
Matsuo Y; Drexler HG; Takeuchi M; Orita K
Leuk Lymphoma; 1999 Nov; 35(5-6):513-26. PubMed ID: 10609789
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of thymopoietin transcripts in different hematopoietic cell lines.
Berger R; Theodor L; Brok-Simoni F; Ben-Bassat H; Trakhtenbrot L; Shoham J; Rechavi G
Acta Haematol; 1995; 93(2-4):62-6. PubMed ID: 7639053
[TBL] [Abstract][Full Text] [Related]
14. Chronic myelogenous leukemia and acute lymphoblastic leukemia occurring in the course of polycythemia vera.
Roth AD; Oral A; Przepiorka D; Gollin SM; Chervenick PA
Am J Hematol; 1993 Jun; 43(2):123-8. PubMed ID: 8342539
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
17. T-lymphoblastic transformation of chronic myelocytic leukemia following T-lymphoblastic and myeloblastic biphenotypic crisis in the lymph nodes with rearrangement of bcr and TCR-beta genes.
Hirose Y; Tachibana J; Takiguchi T; Tatsumi E; Konda S
Eur J Haematol; 1990 Nov; 45(5):282-4. PubMed ID: 2175708
[No Abstract] [Full Text] [Related]
18. A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia.
Matsuo Y; Drexler HG; Takeuchi M; Orita K
Leuk Res; 1999 Aug; 23(8):731-40. PubMed ID: 10456671
[TBL] [Abstract][Full Text] [Related]
19. c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells.
Brizzi MF; Rosso A; Dentelli P; Ferrero D; Lanfrancone L; Pegoraro L
Exp Hematol; 1998 Dec; 26(13):1229-39. PubMed ID: 9845379
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between the persistence of the BCR/ABL gene and relapse in adult patients with acute lymphoblastic leukemia].
Anguita E; Villegas A; González FA; del Potro E; Martínez R; Alvarez A; Díaz-Mediavilla J; Ferro MT; Espinós D
Med Clin (Barc); 1999 Apr; 112(13):481-4. PubMed ID: 10353112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
